92% Of Second-Generation Antipsychotic Drug Prescriptions For Medicaid-Enrolled Children Were Off-Label

A federal review of Medicaid fee-for-service (FFS) claims in five states for second-generation antipsychotics (SGAs) prescribed to children ages 0 to 17 found that 92% were prescribed off-label, while only 8% were prescribed for a medically accepted pediatric indication. The review covered a sample of 687 FFS Medicaid claims for SGAs prescribed to children in California, Florida, Illinois, New York, and Texas. In 2011, these states represented 39% of total Medicaid payments for SGAs. The review found one or more quality of care concerns in 67% of claims; 49% of claims had two or more quality . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.